Actavis Plc and Allergan Inc. Chief Executive Officers Discuss Merger

Brent Saunders, chief executive officer of Actavis Plc, speaks during a Bloomberg Television interview in New York, U.S., on Monday, Nov. 24, 2014. Actavis Plc outspent rival Valeant Pharmaceuticals International Inc. in the $64 billion contest for Botox-maker Allergan Inc. Photographer: Scott Eells/Bloomberg via Getty Images
Brent Saunders, chief executive officer of Actavis Plc, speaks during a Bloomberg Television interview in New York, U.S., on Monday, Nov. 24, 2014. Actavis Plc outspent rival Valeant Pharmaceuticals International Inc. in the $64 billion contest for Botox-maker Allergan Inc. Photographer: Scott Eells/Bloomberg via Getty Images
Actavis Plc and Allergan Inc. Chief Executive Officers Discuss Merger
PURCHASE A LICENSE
How can I use this image?
kr. 3.000,00
DKK

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
459519494
Collection:
Bloomberg
Date created:
November 24, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ACTAVIS ALLERGAN DEAL
Max file size:
3679 x 2432 px (12.26 x 8.11 in) - 300 dpi - 520 KB